Skip to content
DraconiticResearch
Search Sources API
226,742 studies31 sourcesUpdated 47 min ago
Peer-reviewedCC BY-NCHealth science reports

Awareness and Acceptance of Gene Therapy for Sickle Cell Disease Among Individuals From the Eastern Province of Saudi Arabia: A Cross-Sectional Study.

2 more authors
  1. 1College of Medicine Imam Abdulrahman Bin Faisal University Dammam Saudi Arabia.
  2. 2School of Medicine University College Dublin Dublin Ireland.
  3. 3Department of Biochemistry, College of Medicine Imam Abdulrahman Bin Faisal University Dammam Saudi Arabia.

Abstract

Background and aims

Public acceptance is important for implementing gene therapy for sickle cell disease (SCD), particularly in regions with a high disease burden. This study assessed self-perceived knowledge, misconceptions, health literacy, quality of life, and attitudes toward SCD gene therapy among adults from or residing in the Eastern Province of Saudi Arabia.Methods

In this cross-sectional study, 1005 adults completed a structured questionnaire between June and November 2025. Measures included SCD history, perceived knowledge and attitudes toward gene therapy, HLS-SF12 health literacy, and EQ-5D-5L/EQ-VAS health status. Associations were examined using non-parametric tests and multivariable regression models.Results

Self-perceived knowledge of gene therapy side effects was consistently the lowest across all educational levels, with a median score of 0. Overall self-perceived knowledge showed weak positive correlations with gene therapy attitudes (ρ = 0.11-0.19). Higher health literacy was associated with more favorable attitude and knowledge outcomes; adjusted ORs for outcomes meeting the proportional-odds assumption ranged from 1.60 to 2.32 (all p < 0.001). For community acceptability, the health literacy effect varied across thresholds, with adjusted ORs ranging from 1.62 to 2.86 (overall p < 0.001). Among participants with low community acceptability, reported concerns were associated with willingness and family discussion outcomes, although effect sizes were small (ε² = 0.009-0.015). Participants with SCD also reported lower EQ-VAS scores than those without SCD (median 85 vs 90; p = 0.008).Conclusion

Important gaps remain in patients' perceived knowledge of gene therapy, particularly regarding side effects. Health literacy was consistently associated with more favorable knowledge and attitudes, although several associations were small. These findings support targeted education addressing knowledge gaps, uncertainty, and relevant sociocultural concerns.

Related

  1. Awareness and acceptance of Jordanian women of egg freezing technology: a cross-sectional study
    Dana Al-Zoebi, Omar F. Khabour
    Global BioethicsPeer-reviewedCC BY 4.0Full textObstetrics, gynaecology & paediatricsPMC
  2. Factors associated with acceptance of preventive treatment among older adults with latent tuberculosis infection in Huzhou, Zhejiang province: a cross-sectional study.
    Zhongrong Yang, Zhipeng Zu, Xiuxiu Sun +18
    Frontiers in cellular and infection microbiologyPeer-reviewedCC BYFull textInfectious diseaseEurope PMCPMC
  3. Awareness, Attitudes, and Contraceptive Acceptance Among Women Attending a Tertiary-Care Center in Delhi: A Cross-Sectional Study
    Suman Lata Mendiratta, Suman Dath S, Ankita Sinha
    CureusPeer-reviewedCC BYFull textEpidemiology & public healthEurope PMCPMC
  4. A brief acceptance and commitment therapy intervention for individuals at risk of neurodegenerative disease: A translational study in inherited prion disease
    Rhianna Brien, Lilian Dindo, Rachel Williams +5
    NeurotherapeuticsPeer-reviewedCC BYFull textPsychiatry & mental healthDOAJ
  5. A cross-sectional study of the prevalence and correlates of post-traumatic stress among people attending acceptance and commitment therapy for chronic pain
    Kezia Kadri, Cara Keating, Madeleine Anderson +3
    British journal of painPeer-reviewedCC BYFull textGeneral medicineEurope PMC
BibTeX
@article{alrezq2026awareness,
  title = {{Awareness and Acceptance of Gene Therapy for Sickle Cell Disease Among Individuals From the Eastern Province of Saudi Arabia: A Cross-Sectional Study.}},
  author = {Dana A Alrezq and Fatimah J Al Darwish and Naba A Almatrood and Marwa A Aljowaid and Jana J Alali and Batool A Ojayan and Zahra A Alkhamis and Fatimah H Alturki and Batool S Alshurafa and Baqir J Albin Ahmed and Razan Alborhan and Chittibabu Vatte and Amein K Alali and Alawi Habara},
  journal = {Health science reports},
  year = {2026},
  month = nov,
  doi = {10.1002/hsr2.73473},
  url = {https://europepmc.org/article/MED/43011792},
  note = {CC BY-NC},
}
RIS
TY  - JOUR
TI  - Awareness and Acceptance of Gene Therapy for Sickle Cell Disease Among Individuals From the Eastern Province of Saudi Arabia: A Cross-Sectional Study.
AU  - Dana A Alrezq
AU  - Fatimah J Al Darwish
AU  - Naba A Almatrood
AU  - Marwa A Aljowaid
AU  - Jana J Alali
AU  - Batool A Ojayan
AU  - Zahra A Alkhamis
AU  - Fatimah H Alturki
AU  - Batool S Alshurafa
AU  - Baqir J Albin Ahmed
AU  - Razan Alborhan
AU  - Chittibabu Vatte
AU  - Amein K Alali
AU  - Alawi Habara
PY  - 2026
DA  - 2026/11/10
JO  - Health science reports
DO  - 10.1002/hsr2.73473
UR  - https://europepmc.org/article/MED/43011792
AB  - Background and aims  Public acceptance is important for implementing gene therapy for sickle cell disease (SCD), particularly in regions with a high disease burden. This study assessed self-perceived knowledge, misconceptions, health literacy, quality of life, and attitudes toward SCD gene therapy among adults from or residing in the Eastern Province of Saudi Arabia.Methods  In this cross-sectional study, 1005 adults completed a structured questionnaire between June and November 2025. Measures included SCD history, perceived knowledge and attitudes toward gene therapy, HLS-SF12 health literacy, and EQ-5D-5L/EQ-VAS health status. Associations were examined using non-parametric tests and multivariable regression models.Results  Self-perceived knowledge of gene therapy side effects was consistently the lowest across all educational levels, with a median score of 0. Overall self-perceived knowledge showed weak positive correlations with gene therapy attitudes (ρ = 0.11-0.19). Higher health literacy was associated with more favorable attitude and knowledge outcomes; adjusted ORs for outcomes meeting the proportional-odds assumption ranged from 1.60 to 2.32 (all p < 0.001). For community acceptability, the health literacy effect varied across thresholds, with adjusted ORs ranging from 1.62 to 2.86 (overall p < 0.001). Among participants with low community acceptability, reported concerns were associated with willingness and family discussion outcomes, although effect sizes were small (ε² = 0.009-0.015). Participants with SCD also reported lower EQ-VAS scores than those without SCD (median 85 vs 90; p = 0.008).Conclusion  Important gaps remain in patients' perceived knowledge of gene therapy, particularly regarding side effects. Health literacy was consistently associated with more favorable knowledge and attitudes, although several associations were small. These findings support targeted education addressing knowledge gaps, uncertainty, and relevant sociocultural concerns.
SN  - 2398-8835
ER  -